Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.3%

7 terminated/withdrawn out of 112 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

32%

36 trials in Phase 3/4

Results Transparency

13%

7 of 56 completed trials have results

Key Signals

27 recruiting7 with results

Enrollment Performance

Analytics

N/A

34(36.2%)

Phase 4

23(24.5%)

Phase 2

16(17.0%)

Phase 3

13(13.8%)

Phase 1

7(7.4%)

Early Phase 1

1(1.1%)

94Total

N/A(34)

Phase 4(23)

Phase 2(16)

Phase 3(13)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (112)

Showing 20 of 112 trials

NCT05983159Phase 2Recruiting

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Role: lead

NCT05204550Phase 2Completed

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Role: lead

NCT07251790Not ApplicableRecruiting

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

Role: lead

NCT05770622Phase 4Recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

Role: lead

NCT07532941Phase 4Not Yet Recruiting

Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'

Role: lead

NCT07325305Not ApplicableRecruiting

Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes

Role: lead

NCT07209657Not ApplicableNot Yet Recruiting

Describing the Effect of Familiar Song on Arousal and Awareness for Children With Disorders of Consciousness (DoC)

Role: lead

NCT07522346Not ApplicableNot Yet Recruiting

deMISTify: The Impact of Ventilator Pressure Levels During Minimally Invasive Surfactant Therapy on Lung Aeration in Preterm Infants

Role: lead

NCT06574789Phase 2Recruiting

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

Role: lead

NCT06647225Not ApplicableRecruiting

Using Artificial Intelligence to Screen for Hip Dysplasia

Role: lead

NCT06935890Phase 4Recruiting

Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

Role: lead

NCT05265065Phase 3Completed

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Role: lead

NCT05500326Phase 2Active Not Recruiting

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

Role: lead

NCT04948463Phase 4Completed

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

Role: lead

NCT06918665Phase 1Suspended

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

Role: lead

NCT06992141Early Phase 1Completed

A Strep Throat Controlled Human Infection Trial in Healthy Adults

Role: lead

NCT07151079Not ApplicableNot Yet Recruiting

TAG TEAM - Trans Adolescent Group Therapy

Role: lead

NCT06847282Recruiting

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

Role: collaborator

NCT06529536Phase 4Recruiting

Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.

Role: lead

NCT06686446Not ApplicableTerminated

Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial

Role: lead